Structural Heart Devices Market Size, Share, Trends, Growth Outlook

Structural Heart Devices Market is estimated to increase at a Compounded Annual Growth Rate of 10.8% CAGR over the forecast period from 2024 to 2030

The Structural Heart Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Herat Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems, Annuloplasty Rings, Others), By Procedure (Replacement Procedures, Repair Procedures).

An Introduction to Structural Heart Devices Market in 2024

Structural Heart Devices are specialized medical devices used in the treatment of structural heart diseases, which affect the anatomy and function of the heart valves, chambers, or walls. Structural heart diseases include conditions such as valvular heart disease, congenital heart defects, and cardiac arrhythmias. Structural heart devices encompass a wide range of minimally invasive interventions, including transcatheter heart valve replacement (TAVR), transcatheter mitral valve repair (TMVR), left atrial appendage closure (LAAC), and septal defect closure. These devices are designed to repair or replace damaged or malfunctioning heart structures through catheter-based procedures, avoiding the need for open-heart surgery. Structural heart devices offer advantages such as reduced recovery times, improved procedural outcomes, and lower risk of complications compared to traditional surgical approaches. With ongoing innovations in device design, imaging guidance, and patient selection criteria, structural heart devices continue to expand treatment options for patients with structural heart diseases, improving quality of life and reducing mortality rates.

Market Trend: Minimally Invasive Procedures for Structural Heart Repair

A significant trend in the structural heart devices market is the increasing adoption of minimally invasive procedures for structural heart repair. Traditional open-heart surgeries for structural heart conditions, such as atrial septal defects (ASDs), patent foramen ovale (PFO), and valvular heart diseases, often involve extensive incisions and prolonged recovery times. However, there is a growing shift towards minimally invasive approaches, such as transcatheter techniques, which offer several advantages including reduced trauma, shorter hospital stays, faster recovery, and improved patient outcomes. These minimally invasive procedures utilize specialized structural heart devices, such as transcatheter heart valves, septal occluders, and left atrial appendage closure devices, to repair or replace damaged cardiac structures through catheter-based delivery systems. The trend towards minimally invasive structural heart interventions reflects the ongoing efforts to improve patient care, enhance procedural safety, and optimize healthcare resource utilization in the management of structural heart diseases.

Market Driver: Aging Population and Increasing Prevalence of Structural Heart Conditions

A key driver for the structural heart devices market is the aging population and the increasing prevalence of structural heart conditions. With aging comes a higher incidence of degenerative heart diseases, including aortic stenosis, mitral regurgitation, and atrial fibrillation, which often necessitate intervention to restore cardiac function and improve patient quality of life. Additionally, advancements in medical technology and improved access to healthcare services have led to the diagnosis and treatment of structural heart conditions in a larger segment of the population. As a result, there is a growing demand for structural heart devices to address the diverse needs of patients with structural heart diseases, ranging from congenital abnormalities to acquired valvular and structural defects. The aging demographic and rising prevalence of structural heart conditions drive the adoption of structural heart devices, stimulating market growth and innovation in the sector.

Market Opportunity: Expansion into Transcatheter Mitral Valve Interventions

An emerging opportunity within the structural heart devices market lies in the expansion into transcatheter mitral valve interventions. While transcatheter aortic valve replacement (TAVR) has gained widespread acceptance as a minimally invasive treatment for aortic valve diseases, transcatheter approaches for mitral valve repair and replacement are still in the early stages of development and adoption. Mitral valve diseases, such as mitral regurgitation and mitral stenosis, pose significant clinical challenges and are associated with poor outcomes if left untreated. However, traditional surgical interventions for mitral valve repair or replacement carry inherent risks, particularly in high-risk or elderly patients. Transcatheter mitral valve interventions offer a promising alternative by enabling less invasive and safer procedures for mitral valve repair or replacement using specialized devices delivered through catheter-based techniques. By investing in research and development efforts focused on transcatheter mitral valve technologies, manufacturers can capitalize on the growing demand for minimally invasive solutions for mitral valve diseases, expand their product portfolios, and address unmet clinical needs in the management of structural heart conditions.

Structural Heart Devices Market Share Analysis: Transcatheter Heart Valves Product Segment is the fastest growing segment over the forecast period to 2030

Among the segments listed, the transcatheter heart valves product segment is experiencing the fastest growth in the structural heart devices market. This growth is driven by several factors. Transcatheter heart valves offer a less invasive alternative to traditional surgical heart valve replacement procedures, such as surgical heart valves, particularly in high-risk or elderly patients. As the aging population increases worldwide and the prevalence of structural heart diseases rises, there is a growing demand for minimally invasive treatment options. Transcatheter heart valves provide excellent hemodynamic performance and comparable clinical outcomes to surgical options while offering advantages such as reduced recovery time, shorter hospital stays, and fewer postoperative complications. Additionally, advancements in transcatheter heart valve technology, including improvements in valve design, delivery systems, and imaging techniques, contribute to their increasing adoption in structural heart interventions. With a shift towards less invasive procedures and the expanding applications of transcatheter heart valves in both replacement and repair procedures, this segment emerges as the fastest-growing segment in the structural heart devices market.

Structural Heart Devices Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Biomerics LLC, Boston Scientific Corp, CardioKinetix Inc, Comed B.V., Edwards Lifesciences Corp, JenaValve Technology Inc, LivaNova PLC, Medtronic plc, St. Jude Medical LLC

Structural Heart Devices Market Segmentation

By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Structural Heart Devices Market Companies

Abbott Laboratories
Biomerics LLC
Boston Scientific Corp
CardioKinetix Inc
Comed B.V.
Edwards Lifesciences Corp
JenaValve Technology Inc
LivaNova PLC
Medtronic plc
St. Jude Medical LLC

Reasons to Buy the Structural Heart Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Structural Heart Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Structural Heart Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Structural Heart Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Structural Heart Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Structural Heart Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Structural Heart Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Structural Heart Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Structural Heart Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Structural Heart Devices Industry
4.2 Key Market Trends in Structural Heart Devices Industry
4.3 Potential Opportunities in Structural Heart Devices Industry
4.4 Key Challenges in Structural Heart Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Structural Heart Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Structural Heart Devices Market Outlook by Segments
7.1 Structural Heart Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty

8 North America Structural Heart Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Structural Heart Devices Markets in 2024
8.2 North America Structural Heart Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Structural Heart Devices Market size Outlook by Segments, 2021-2030
By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty

9 Europe Structural Heart Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Structural Heart Devices Markets in 2024
9.2 Europe Structural Heart Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Structural Heart Devices Market Size Outlook by Segments, 2021-2030
By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty

10 Asia Pacific Structural Heart Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Structural Heart Devices Markets in 2024
10.2 Asia Pacific Structural Heart Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Structural Heart Devices Market size Outlook by Segments, 2021-2030
By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty

11 South America Structural Heart Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Structural Heart Devices Markets in 2024
11.2 South America Structural Heart Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Structural Heart Devices Market size Outlook by Segments, 2021-2030
By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty
12 Middle East and Africa Structural Heart Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Structural Heart Devices Markets in 2024
12.2 Middle East and Africa Structural Heart Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Structural Heart Devices Market size Outlook by Segments, 2021-2030
By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Biomerics LLC
Boston Scientific Corp
CardioKinetix Inc
Comed B.V.
Edwards Lifesciences Corp
JenaValve Technology Inc
LivaNova PLC
Medtronic plc
St. Jude Medical LLC

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Herat Valve Devices
Surgical Heart Valves
Transcatheter Heart Valves
Occluders and Delivery Systems
Annuloplasty Rings
Others
By Procedure
Replacement Procedures
-TAVR Procedures
-SAVR Procedures
Repair Procedures
-Closure Procedures
-Annuloplasty
-Valvuloplasty
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)